Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS hydromorphone versus placebo for osteoarthritis pain
2006-006911-60Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing OROS hydromorphone hydrochloride with Placebo (2 arms). Primary endpoint: Mean Brief Pain Inventory item 5 score. Started May 2007; status: completed.
02
Drugs
hydromorphone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-006911-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006911-60.